Nuvectis Pharma
NVCT
NVCT
31 hedge funds and large institutions have $7.15M invested in Nuvectis Pharma in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$984K | |
| 2 | +$442K | |
| 3 | +$135K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$131K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$104K |
Top Sellers
| 1 | -$348K | |
| 2 | -$210K | |
| 3 | -$99.4K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$83.2K |
| 5 |
Citigroup
New York
|
-$55.9K |